Scarica l'app Stockscreener
1.74
9.43%
0.15
Dopo l'orario di chiusura:
1.72
-0.02
-1.15%
Precedente Chiudi:
$1.59
Aprire:
$1.61
Volume 24 ore:
395.59K
Relative Volume:
1.93
Capitalizzazione di mercato:
$79.79M
Reddito:
$134.00K
Utile/perdita netta:
$-9.93M
Rapporto P/E:
-5.1176
EPS:
-0.34
Flusso di cassa netto:
$-6.72M
1 W Prestazione:
-10.31%
1M Prestazione:
-18.31%
6M Prestazione:
-2.25%
1 anno Prestazione:
-28.98%
Intervallo 1D:
$1.60
$1.755
Intervallo di 1 settimana:
$1.57
$1.9875
Portata 52W:
$1.5006
$3.22
Entera Bio Ltd Stock (ENTX) Company Profile
Nome
Entera Bio Ltd
Settore
Industria
Telefono
972-2-532-7151
Indirizzo
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Confronta ENTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
1.74 | 72.91M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-22 | Iniziato | Aegis Capital | Buy |
Entera Bio Ltd Borsa (ENTX) Ultime notizie
Will Entera Bio Ltd. stock remain a Wall Street favoriteJuly 2025 Momentum & Technical Confirmation Alerts - ulpravda.ru
Is Entera Bio Ltd. stock oversold or undervalued2025 Buyback Activity & Reliable Price Action Trade Plans - ulpravda.ru
What margin trends mean for Entera Bio Ltd. stockJuly 2025 Trends & Low Drawdown Investment Ideas - ulpravda.ru
Is Entera Bio Ltd. (5DT) stock prepared for digital transitionRate Hike & Long-Term Capital Growth Ideas - ulpravda.ru
Entera Bio Ltd.Ordinary Shares (NQ: ENTX - FinancialContent
Breakout Watch: Can Entera Bio Ltd 5DT stock surprise with quarterly results2025 Technical Overview & Low Drawdown Momentum Ideas - moha.gov.vn
[Form 4] Entera Bio Ltd. Insider Trading Activity - Stock Titan
Entera Bio Ltd. (NASDAQ: ENTX) director reports 2026 share and option grants - Stock Titan
Entera Bio (ENTX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation - Yahoo Finance
Entera Bio (NASDAQ:ENTX) CEO Miranda Jayne Toledano Acquires 11,000 Shares - MarketBeat
Entera Bio Ltd. Stock (ENTX) Opinions on Insider Buying and Clinical Updates - Quiver Quantitative
ENTX Insider Trading - Quiver Quantitative
Aug Retail: What margin trends mean for Entera Bio Ltd stockPortfolio Performance Report & Daily Risk Controlled Trade Plans - moha.gov.vn
Entera Bio (NASDAQ:ENTX) Rating Increased to Sell at Wall Street Zen - MarketBeat
FY2025 EPS Estimates for Entera Bio Boosted by HC Wainwright - Defense World
HC Wainwright Increases Earnings Estimates for Entera Bio - MarketBeat
H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint - Investing.com Australia
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation - marketscreener.com
Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) - Sahm
FDA clears new way to test osteoporosis drugs, aiming to cut trial time - Stock Titan
Entera Bio’s oral PTH analog shows sustained calcium response By Investing.com - Investing.com Nigeria
Entera Bio’s oral PTH analog shows sustained calcium response - Investing.com
Entera Bio Ltd. Announces Promising Preclinical Data for Once-Daily Oral PTH Treatment in Hypoparathyroidism - Quiver Quantitative
New once-a-day pill aims to replace daily injections for rare calcium disorder - Stock Titan
Entera Bio Ltd. Announces New Data Supporting Further Development of A Proprietary First-In-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) - MarketScreener
Can Entera Bio Ltd. stock beat analyst upgradesJuly 2025 Earnings & Safe Investment Capital Preservation Plans - Улправда
How analysts rate Entera Bio Ltd. stock todayQuarterly Portfolio Report & Advanced Technical Analysis Signals - Улправда
Can Entera Bio Ltd. stock sustain market leadership2025 Growth vs Value & Accurate Buy Signal Notifications - Улправда
Why Entera Bio Ltd. stock appeals to analystsJuly 2025 Update & Daily Volume Surge Trade Alerts - Улправда
Can Entera Bio Ltd. stock hit analyst price targets2025 Bull vs Bear & Expert Curated Trade Setups - Улправда
How Entera Bio Ltd. stock trades before earningsWeekly Investment Summary & Smart Swing Trading Alerts - Улправда
Day Trade: Can Entera Bio Ltd. stock beat analyst upgrades2025 Key Lessons & Stepwise Trade Signal Guides - Улправда
Chart Watch: Can Entera Bio Ltd. stock sustain market leadershipIndex Update & Verified Momentum Stock Alerts - Улправда
Pharma News: Will Entera Bio Ltd stock outperform Dow Jones indexNew Guidance & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
Entera Bio (NASDAQ:ENTX) Trading Down 0.9%Here's What Happened - MarketBeat
Entera Bio Ltd. (ENTX) Drops 5% in Pre-market: No Clear Catalyst - Stocks Telegraph
Is Entera Bio Ltd. (5DT) stock dividend growth reliableJuly 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser
Why Entera Bio Ltd. (5DT) stock appeals to dividend investorsQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser
Will Entera Bio Ltd. (5DT) stock sustain uptrend momentumStop Loss & Long-Term Safe Investment Ideas - Newser
Will Entera Bio Ltd. (5DT) stock benefit from infrastructure billMarket Activity Summary & Capital Protection Trade Alerts - Newser
Is Entera Bio Ltd. (5DT) stock good for wealth creationEarnings Trend Report & Reliable Entry Point Trade Alerts - Newser
Can Entera Bio Ltd. (5DT) stock sustain revenue momentumWeekly Market Report & Risk Controlled Daily Trade Plans - Newser
Will Entera Bio Ltd. (5DT) stock issue positive guidanceJuly 2025 Market Mood & AI Driven Stock Price Forecasts - Newser
Will Entera Bio Ltd. (5DT) stock enhance shareholder valueJuly 2025 Spike Watch & Low Risk High Win Rate Picks - Newser
How Entera Bio Ltd. (5DT) stock expands through international marketsRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Will Entera Bio Ltd. (5DT) stock hit analyst forecasts2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
Can Entera Bio Ltd. (5DT) stock expand revenue streams2025 Short Interest & High Return Trade Guides - Newser
Entera Bio Ltd Azioni (ENTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):